DEBORAH ZIPIN GLICK M.D. NPI 1962450783

NPI Details

Deborah Zipin Glick, M.D. is a medical oncology internal medicine in Naples, FL with 28 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Deborah Zipin Glick, M.D. NPI is 1962450783. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: TULANE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1998

The provider's business location address is:

708 GOODLETTE RD NORTH STE 200
NAPLES, FL
ZIP 34102-644
Phone: (239) 231-7260
Fax: (239) 947-5298

The NPI 1962450783 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Iron binding capacity (HCPCS:83550)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Folic acid level, serum (HCPCS:82746)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Red blood count, manual test (HCPCS:85044)
• Uric acid level, blood (HCPCS:84550)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Magnesium level (HCPCS:83735)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Drawing of blood for a medical problem (HCPCS:99195)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Red blood count, automated test (HCPCS:85045)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Erythropoietin (protein) level (HCPCS:82668)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Phosphate level (HCPCS:84100)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Blood test, clotting time (HCPCS:85610)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Automated urinalysis test (HCPCS:81003)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Homocysteine (amino acid) level (HCPCS:83090)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Hepatitis c antibody measurement (HCPCS:86803)
• Testosterone (hormone) level, total (HCPCS:84403)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Rheumatoid factor level (HCPCS:86431)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)

The enumeration date for this NPI number is 5/4/2006 and was last updated on 11/10/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.